Compare GITS & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GITS | NVNO |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | South Korea | United States |
| Employees | 12 | 37 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 7.2M |
| IPO Year | N/A | N/A |
| Metric | GITS | NVNO |
|---|---|---|
| Price | $2.41 | $11.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 35.8K | 13.7K |
| Earning Date | 05-19-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $140.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $0.30 |
| 52 Week High | $7.09 | $12.85 |
| Indicator | GITS | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 54.62 |
| Support Level | $2.08 | $9.78 |
| Resistance Level | $2.40 | $12.69 |
| Average True Range (ATR) | 0.25 | 0.76 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 23.29 | 57.27 |
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.